AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Improving Visual Quality in Patients With Irregular Corneas Using Asymmetrical Toric Intraocular Lenses

RecruitingNAAges 21 Years - anyAllJohannes Kepler University of Linz
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cataract surgery in patients with irregular corneas presents unique challenges, primarily due to the high variability in keratometry and corneal tomography measurements, which complicates accurate intraocular lens (IOL) calculations. In these patients, therapeutic options are currently limited to either non-toric IOLs and rigid contact lenses postoperatively or conventional toric IOLs for the reduction of total astigmatism within cataract surgery. While conventional toric IOLs may be beneficial in selected cases with a stable astigmatic pattern and clear axis, their effectiveness is largely limited, as significant irregularity and higher order aberrations reduce predictability, accuracy of formulae, and refractive outcomes. Therefore, the development of a reliable method to reduce total astigmatism - including irregular components - would represent a major advancement, potentially improv

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 21 years or older * Scheduled cataract surgery * At least 1.75 D of total astigmatism in the CASIA2 measurement * At least 0.75 D of asymmetry or higher order irregularity within the 6mm zone of the real (total) index corneal refractive map of the CASIA2 measurements Exclusion Criteria: * Relevant central corneal scars * PEX, previous ocular surgery, severe trauma or any pathology that could lead to an unstable capsular bag * Combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery) * Postoperative best corrected distance visual acuity below 0.3 Snellen decimal * Pregnancy
๐Ÿ’Š

What it tests

  • AMILens Individual
๐Ÿ“

Where

1 site
Kepler University Clinic, Department for Ophthalmology and Optometry
Linz, Austria
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy